Changgeng Qian
Corporate Officer/Principal bei Central South University
Profil
Changgeng Qian is a professor at Central South University since 1992.
Prior to this, he worked as Head-Pharmacology at CytoMed, Inc. from 1992 to 1995, Senior Research Scientist at LeukoSite, Inc. from 1996 to 1999, and Senior Scientist at Millennium Pharmaceuticals, Inc. from 1999 to 2001.
From 2010 to 2012, he worked as Senior VP-Discovery & Preclinical Development at Curis, Inc. Dr. Qian holds a doctorate degree from Central South University.
Aktive Positionen von Changgeng Qian
Unternehmen | Position | Beginn |
---|---|---|
Central South University | Corporate Officer/Principal | 01.01.1992 |
Ehemalige bekannte Positionen von Changgeng Qian
Unternehmen | Position | Ende |
---|---|---|
CURIS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 16.02.2012 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2001 |
LeukoSite, Inc.
LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.1999 |
CytoMed, Inc.
CytoMed, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., CytoMed, Inc. is a company that develops therapeutics for cancer treatment. The company is based in Cambridge, MA. CytoMed was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on February 12, 1999 for $19.29 million. | Corporate Officer/Principal | 01.12.1995 |
Ausbildung von Changgeng Qian
Central South University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CURIS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
LeukoSite, Inc.
LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Health Technology |
CytoMed, Inc.
CytoMed, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., CytoMed, Inc. is a company that develops therapeutics for cancer treatment. The company is based in Cambridge, MA. CytoMed was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on February 12, 1999 for $19.29 million. | Health Technology |